Larson Financial Group LLC - SAREPTA THERAPEUTICS INC ownership

SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 416 filers reported holding SAREPTA THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.97 and the average weighting 0.3%.

Quarter-by-quarter ownership
Larson Financial Group LLC ownership history of SAREPTA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$61,701
+7.8%
509
+1.8%
0.01%0.0%
Q2 2023$57,260
-16.9%
5000.0%0.01%
-14.3%
Q1 2023$68,915
+6.4%
5000.0%0.01%
-12.5%
Q4 2022$64,790
+17.8%
5000.0%0.01%0.0%
Q3 2022$55,000
+48.6%
5000.0%0.01%
+33.3%
Q2 2022$37,000
-5.1%
5000.0%0.01%0.0%
Q1 2022$39,000
-13.3%
5000.0%0.01%
-14.3%
Q4 2021$45,000
-2.2%
5000.0%0.01%
-22.2%
Q3 2021$46,000
+17.9%
5000.0%0.01%0.0%
Q2 2021$39,000
+5.4%
5000.0%0.01%
-18.2%
Q1 2021$37,000
-56.5%
5000.0%0.01%
-62.1%
Q4 2020$85,000
+21.4%
5000.0%0.03%0.0%
Q3 2020$70,000
-12.5%
5000.0%0.03%
-23.7%
Q2 2020$80,000
+63.3%
5000.0%0.04%
+22.6%
Q1 2020$49,000
-24.6%
5000.0%0.03%
-16.2%
Q4 2019$65,000
+71.1%
5000.0%0.04%
+48.0%
Q3 2019$38,000
-50.0%
5000.0%0.02%
-55.4%
Q2 2019$76,000
+26.7%
5000.0%0.06%
+16.7%
Q1 2019$60,000
+9.1%
5000.0%0.05%
-5.9%
Q4 2018$55,0005000.05%
Other shareholders
SAREPTA THERAPEUTICS INC shareholders Q4 2022
NameSharesValueWeighting ↓
Perceptive Advisors 2,878,979$69,182,0007.27%
Eventide Asset Management 259,100$6,226,0000.97%
GLADE BROOK CAPITAL PARTNERS LLC 251,000$6,032,0000.93%
IMS Capital Management 32,215$774,0000.91%
Perceptive Advisors 350,000$8,413,0000.88%
Benchmark Capital Advisors 34,900$839,0000.58%
BECK CAPITAL MANAGEMENT, LLC 24,744$636,0000.49%
SABBY MANAGEMENT, LLC 352,100$8,461,0000.47%
Hatteras Alternative Mutual Funds, LLC 39,404$947,0000.46%
Potomac Capital Management, Inc. 22,100$531,0000.45%
View complete list of SAREPTA THERAPEUTICS INC shareholders